SCHOTT Pharma AG & Co. KGaA Capital Reinvestment Ratio
SCHOTT Pharma AG & Co. KGaA capital reinvestment ratio. SCHOTT Pharma AG & Co. KGaA (1SXP) has a Capital Reinvestment Ratio of 0.85x as of September 2024, meaning it reinvests 1% of its operating cash flow (€75.97 Million) in capital expenditures (€64.68 Million). See how much free cash does SCHOTT Pharma AG & Co. KGaA generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of SCHOTT Pharma AG & Co. KGaA (2020–2024)
Capital reinvestment ratio of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. This chart tracks SCHOTT Pharma AG & Co. KGaA's Capital Reinvestment Ratio across 5 annual periods. See 1SXP financial flexibility index to measure the company's free cash flow as a share of total liabilities.
SCHOTT Pharma AG & Co. KGaA Capital Reinvestment Ratio by Year (2020–2024)
SCHOTT Pharma AG & Co. KGaA capital reinvestment ratio by year from 2020 to 2024. For the full cash flow conversion analysis, see SCHOTT Pharma AG & Co. KGaA cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.64x | €225.33 Million | €145.30 Million | ▼ -33.3% |
| 2023 | 0.97x | €181.65 Million | €175.52 Million | ▲ +15.3% |
| 2022 | 0.84x | €182.12 Million | €152.69 Million | ▲ +12.4% |
| 2021 | 0.75x | €132.21 Million | €98.63 Million | ▼ -8.7% |
| 2020 | 0.82x | €104.40 Million | €85.31 Million | — |